| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/25/2005 | US6846497 Rapidly expanding starches with altered crystalline structure |
| 01/25/2005 | US6846495 Respiratory system disorders; dextromethorphan in anhydrous solvents |
| 01/25/2005 | US6846490 Enhance hydrophobicity of a biological surface by applying vernix and a dispersant |
| 01/25/2005 | US6846485 Fish serine proteinase and their pharmaceutical and cosmetic use |
| 01/25/2005 | CA2354695C Compositions and methods for amelioration of human female sexual dysfunction |
| 01/25/2005 | CA2322506C Tissue paper having antimicrobial skin lotion |
| 01/25/2005 | CA2301989C Patch with magnetic field effect |
| 01/25/2005 | CA2228137C Apparatus and methods for improved noninvasive dermal administration of pharmaceuticals |
| 01/25/2005 | CA2204769C Hemorrhoidal compositions and method of use |
| 01/25/2005 | CA2169441C Effervescent system with an alkali- and/or metal-sensitive pharmaceutical active substance and process for producing the same |
| 01/25/2005 | CA2169159C Pharmaceutical composition containing a drug/.beta.-cyclodextrin complex in combination with an acid-base couple |
| 01/25/2005 | CA2146442C Anti-inflammatory factor, method of isolation, and use |
| 01/21/2005 | CA2435632A1 Formulation of powder containing nanoparticles for aerosol delivery to the lung |
| 01/20/2005 | WO2005005954A2 Method, composition and kit for detecting phosphatidylserine (ps) on cell membranes |
| 01/20/2005 | WO2005005548A1 Conjugate of fine porous particles with polymer molecules and utilization thereof |
| 01/20/2005 | WO2005004972A1 Sonophoresis skin care device |
| 01/20/2005 | WO2005004924A1 Active substance excipient system |
| 01/20/2005 | WO2005004923A1 Tablet and process for producing the same |
| 01/20/2005 | WO2005004922A1 Pharmaceutical compositions comprising peranhydrocyclodextrin |
| 01/20/2005 | WO2005004921A1 Solid composition comprising a proton pump inhibitor |
| 01/20/2005 | WO2005004920A1 Stable non-dihydrate azithromycin oral suspensions |
| 01/20/2005 | WO2005004919A2 Extended release systems for macrolide antibiotics |
| 01/20/2005 | WO2005004917A2 Pharmaceutical composition for solubility enhancement of hydrophobic drugs |
| 01/20/2005 | WO2005004916A2 Modified calcium phosphate excipient |
| 01/20/2005 | WO2005004914A1 MEDICINAL COMPOSITION CONTAINING NF-κB DECOY FOR TREATING AND PREVENTING RESPIRATORY DISEASES AND METHOD OF USING THE SAME |
| 01/20/2005 | WO2005004913A1 Pharmaceutical composition containing decoy and method of using the same |
| 01/20/2005 | WO2005004901A1 Method for stabilizing a cryoprecipitate of plasmatic proteins for being subjected to a viral inactivation thermal treatment |
| 01/20/2005 | WO2005004900A1 Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form |
| 01/20/2005 | WO2005004895A2 Compositions and methods for enhanced mucosal delivery of growth hormone |
| 01/20/2005 | WO2005004878A2 Multi-use vessels for vitamin d formulations, preferably administeredat high dose and periodically |
| 01/20/2005 | WO2005004877A1 Inhibition of irritating side effects associated with use of a topical ophthalmic medication |
| 01/20/2005 | WO2005004876A1 Method of preparing an aqueous meloxicam solution and aqueous solution thus produced |
| 01/20/2005 | WO2005004874A1 Stable tetrodotoxin freeze drying medicinal preparation |
| 01/20/2005 | WO2005004860A2 Novel solid pharmaceutical composition comprising amisulpride |
| 01/20/2005 | WO2005004856A1 Antifungal composition |
| 01/20/2005 | WO2005004853A1 Dry powder for inhalation comprising a formoterol salt and ciclesonide |
| 01/20/2005 | WO2005004852A1 Pharmaceutical formulations |
| 01/20/2005 | WO2005004851A1 Tamsulosin core with a coating of polyvinylpyrrolidone and polyvinylacetate |
| 01/20/2005 | WO2005004850A1 Controlled release compositions of betahistine |
| 01/20/2005 | WO2005004849A2 Pharmaceutical formulation comprising levothyroxine sodium |
| 01/20/2005 | WO2005004848A1 The solid dispersion of tacrolimus |
| 01/20/2005 | WO2005004847A1 Novel process |
| 01/20/2005 | WO2005004846A1 Pharmaceutical formulations |
| 01/20/2005 | WO2005004845A1 Pharmaceutical formulations comprising magnesium stearate |
| 01/20/2005 | WO2005004844A1 Hfc solution formulations containing an anticholinergic |
| 01/20/2005 | WO2005004843A1 Microemulsions and its use for preventing airway diseases |
| 01/20/2005 | WO2005004842A2 Formulations for coated microprojections containing non-volatile counterions |
| 01/20/2005 | WO2005004841A1 Drug delivery device |
| 01/20/2005 | WO2005004840A2 Non-gelatin film and method and apparatus for producing same |
| 01/20/2005 | WO2005004839A2 Stable pharmaceutical formulation |
| 01/20/2005 | WO2005004838A1 Pharmaceutical formulations for intranasal administration of protein comprising a chitosan or a derivative thereof |
| 01/20/2005 | WO2005004837A1 Intravaginal drug delivery devices |
| 01/20/2005 | WO2005004836A2 Saquinavir mesylate oral dosage form |
| 01/20/2005 | WO2005004832A1 Sustained release compositions and controlled delivery method |
| 01/20/2005 | WO2005004829A1 Powdery compositions and skin preparation containing the same for external use |
| 01/20/2005 | WO2005004804A2 Compositions and methods for selective dissolution of nascent intravascular blood clots |
| 01/20/2005 | WO2005004763A1 Diffusion layer modulated solids |
| 01/20/2005 | WO2004106411A3 Biodegradable poly(beta-amino esters) and uses thereof |
| 01/20/2005 | WO2004105759A3 Novel long-acting medicament combinations comprising an anticholinergic agent and a $g(b)2-adrenoreceptor antagonist for the treatment of respiratory tract diseases |
| 01/20/2005 | WO2004104292A3 Method for making antimicrobial polyester-containing articles with improved wash durability and articles made thereby |
| 01/20/2005 | WO2004096172A3 Vector for oral administration |
| 01/20/2005 | WO2004093845A3 Ligand-coupled initiator polymers and methods of use |
| 01/20/2005 | WO2004091714A3 Implantable or insertable medical devices containing radiation-crosslinked polymer for controlled delivery of a therapeutic agent |
| 01/20/2005 | WO2004091614A3 Stabilized amlodipine maleate formations |
| 01/20/2005 | WO2004087209A9 Preparation for sustaining therapeutically effective blood concentration of analgesic activity potentiator |
| 01/20/2005 | WO2004082576A3 Direct compressible trehalose solids |
| 01/20/2005 | WO2004078163A3 Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| 01/20/2005 | WO2004078139A3 Therapeutic compositions |
| 01/20/2005 | WO2004071398A3 Pharmaceutical patch |
| 01/20/2005 | WO2004064758A3 Improved oral delivery of peptides |
| 01/20/2005 | WO2004012791A3 Improved injection system |
| 01/20/2005 | WO2003082302A9 Bioadhesive directed somatic cell therapy |
| 01/20/2005 | WO2003057155A3 Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor |
| 01/20/2005 | US20050015117 Method, system and device for treating disorders of the pelvic floor by electrical stimulation of and the delivery of drugs to the left and right pudendal nerves |
| 01/20/2005 | US20050014837 Method for treating ocular hypertension and glaucoma |
| 01/20/2005 | US20050014832 Treatment |
| 01/20/2005 | US20050014828 Compositions containing prodrugs of florfenicol and methods of use |
| 01/20/2005 | US20050014825 Preparation and use of solidified oils |
| 01/20/2005 | US20050014823 Sprayable homogeneous solution containing local anesthetic agent, penetration enhancer, anhydrous volatile solvent and water; fast acting, simple, reliable |
| 01/20/2005 | US20050014693 Transmission and, or amplification of signals; oral or enteric administering, dissolving, absorption of peptide yy; obesity therapy |
| 01/20/2005 | US20050014681 Bioavailability; uniform dispersion, embedding polypeptide and water insoluble carrier |
| 01/20/2005 | US20050014677 Fine particle size protein powder; grinding in suspension media in which substance is insoluble at low temperature |
| 01/20/2005 | US20050014252 Apparatus comprising biodegradable matrix for use in storage and transfer of viable cells to mammals; tissue engineering; regenerative medicine |
| 01/20/2005 | US20050013960 Multi-cored molded article, method of producing the same, and device for producing the same |
| 01/20/2005 | US20050013924 Electrostatically depositing active materials as dry powder onto polymer substrate |
| 01/20/2005 | US20050013902 Containing psyllium or methyl cellulose, vitamins (A, B1, B2, B6, B12, C, D, E), minerals (calcium, magnesium, phosphorus, potassium) and a flavor to mask the taste of the minerals; dry mixes |
| 01/20/2005 | US20050013892 Process and apparatus for combining virgin material and reground material |
| 01/20/2005 | US20050013886 Cigarette substitute and aid to quit tobacco use |
| 01/20/2005 | US20050013881 Topical applying to skins |
| 01/20/2005 | US20050013874 Suspension or particle-solvent mixture system of zinc-containing calcium phosphate microparticles and therapeutic agent for treating zinc deficiency |
| 01/20/2005 | US20050013873 Use of glass compositions for achieving an antioxidative effect |
| 01/20/2005 | US20050013871 Pharmaceutical composition for the treatment of itch |
| 01/20/2005 | US20050013869 Sustained release formulation for carbamates and a method therefor |
| 01/20/2005 | US20050013868 Preparation of submicron sized nanoparticles via dispersion lyophilization |
| 01/20/2005 | US20050013867 Use of proton sequestering agents in drug formulations |
| 01/20/2005 | US20050013866 Particulate vectors for improving oral absorption of active principles |
| 01/20/2005 | US20050013863 Sustained release tablets; multilayer; thin polymer shell |
| 01/20/2005 | US20050013862 Functional powders for oral delivery |
| 01/20/2005 | US20050013861 Agglomerant of microcrystalline cellulose and silica; controlling particle size |
| 01/20/2005 | US20050013860 Controlled release potassium chloride tablets |